slides · global inventory
Quote
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 10,645
Current window 8,071-8,100
Pages 355
Rows per page 30
Component
8,071-8,100 of 10,645
226
The slide uses a direct quote from a Lancet letter to undermine the credibility of the HARMONY 1 trial investigators.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
257
Includes highlighted text emphasizing the shift in sentiment from bullish to skeptical.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
277
The slide uses a Q&A format to validate the prescriber's credentials and patient volume.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
286
The slide highlights a potential safety concern and a perceived lack of transparency or concern from the manufacturer's sales representative.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
309
The slide uses a combination of summary points and direct excerpts from a pharmacology consultant's review to build a case of scientific negligence or misrepresentation.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
312
The slide uses a combination of summary text, a screenshot of the original study abstract, and a pull-quote from an expert review to discredit the study's findings.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
313
Includes a quote from a pharmacology consultant comparing pitolisant to antihistamines.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
323
The slide uses highlighted text to emphasize key admissions of fraud/inducement.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
330
Includes a Q&A transcript excerpt highlighting the 'buddy' system used to submit fake referrals.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
340
The slide uses a Q&A format to highlight the discrepancy between industry standards and Harmony's practices.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
353
The slide uses a Q&A format to highlight systemic issues and potential regulatory non-compliance regarding speaker programs and off-label prescriptions.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
354
The slide uses highlighted text to emphasize key allegations of off-label promotion and retaliation against employees.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
355
The slide uses a Q&A format to build a narrative of corporate malfeasance.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
360
Includes verbatim interview transcripts highlighting the 'crash' after initial launch spikes.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
366
The slide uses direct quotes from physician interviews to build a negative case against the product's market performance.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 1 hit
22
The slide uses a Q&A format to expose potential accounting fraud and product failure.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller Beat · Allegations of accounting irregularities1 hit
39
The slide details the 'founding customer' relationship between Intel and Lasertec, and the subsequent reliance on Ushio for light sources.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller Beat · Technical issues with Lasertec's products1 hit
40
The slide uses a quote from an industry consultant to challenge the 'monopoly' narrative surrounding Lasertec's market position.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller Beat · Technical issues with Lasertec's products1 hit
94
Includes a Q&A excerpt from a GlobalFoundries executive regarding maintenance costs and customer dissatisfaction.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 1 hit
103
The slide uses a Q&A format to highlight technical flaws in the light source technology.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 1 hit
110
The slide presents a critical testimonial from an industry expert to undermine the technical competence of the subject company.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 1 hit
117
The slide uses a Q&A format and direct quotes from former field engineers to substantiate claims of equipment failure.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 1 hit
118
The slide presents a Q&A style interview excerpt highlighting product reliability issues and the scale of support staff required.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 1 hit
127
The slide presents qualitative evidence from industry experts to undermine the credibility of the subject company's technology.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 1 hit
154
The slide presents a Q&A format to highlight technical failures in a competitor's product.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 1 hit
169
The slide provides context for an upcoming expert testimony, highlighting the relationship between Lasertec, Cymer (ASML), and Isteq.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 1 hit
173
The slide uses expert quotes to undermine the viability of Lasertec's light source technology by citing ASML's historical failure with the same supplier.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 1 hit
186
The slide presents a Q&A format to highlight technical failures and customer frustration.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 1 hit
196
The slide uses a narrative format to discredit the target company's core technology through expert testimony.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 1 hit
210
The slide presents a Q&A format documenting industry skepticism regarding Lasertec's technology reliability.Lasertec Corporation (6920) · Scorpion Capital
Activist deck Short seller 1 hit